Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00060918 · ClinicalTrials.gov registry record · Phase 4
Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,210
- Enrollment target
NCT00060918: Completed Phase 4 study, sponsored by GlaxoSmithKline.
NCT00060918 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 1,210 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (134% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00060918, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,210 participants
- Enrollment target
Study Summary
To evaluate the effects of two different antihypertensive medications in the drug class of beta-blockers on control of glucose in Type II diabetic patients with high blood pressure.
Interventions
- DRUG metoprolol
- DRUG carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,210 participants |
| Start Date | 2001-06 |
| Est. Completion | 2004-04 |
| Phase | Phase 4 |
What the finished NCT00060918 record still lists
NCT00060918 is an interventional study that assigns participants to a tested intervention. Its 1,210 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (134% higher).
The record links to 0 conditions, and to 2 interventions - of which metoprolol is the first listed.
NCT00060918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00060918 about?
NCT00060918 is a clinical study titled "Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension". To evaluate the effects of two different antihypertensive medications in the drug class of beta-blockers on control of glucose in Type II diabetic patients with high blood pressure.
What is the current status of trial NCT00060918?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,210 participants. The study started on 2001-06. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00060918?
The interventions under investigation include: metoprolol (DRUG), carvedilol (DRUG).
Who is sponsoring clinical trial NCT00060918?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00060918's enrollment target sits among peer trials
1,210 62nd of 2000 higher than 1,939 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia